Literature DB >> 8769512

Incidence and significance of acid-fast bacilli in sputum smears at the end of antituberculous treatment.

R Vidal1, N Martin-Casabona, A Juan, T Falgueras, M Miravitlles.   

Abstract

OBJECTIVE: A group of patients with pulmonary tuberculosis (PT) who received and correctly completed antituberculous therapy were studied to determine the incidence and significance of positive acid-fast bacilli (AFB) in sputum smears at the end of this treatment.
DESIGN: Retrospective chart review of persons with bacteriologically proved PT. PATIENTS: Of 1,052 patients diagnosed as having PT between 1988 and 1992, 453 who fulfilled the following criteria were included in the study: (1) diagnosis established by positive AFB and positive culture in sputum smears; (2) no previous antituberculous treatment had been received; (3) HIV serologic test results were negative; (4) treatment was correctly completed; (5) they were followed up throughout the period of treatment; and (6) expectoration was still present at the end of treatment and at least two spontaneous sputum samples could be obtained.
RESULTS: Positive AFB of sputum smears were found at the end of treatment in 10 (2.2%) of the 453 patients studied. Five patients had only one positive smear, and the other five had more than one. Of these ten cases, sputum culture was negative in eight, which were considered to be unviable bacilli, and positive for nontuberculous mycobacteria in two. Clinical symptoms or worsening on chest radiograph were observed only in one patient with unviable bacilli, but they were caused by a concomitant nonspecific respiratory tract infection.
CONCLUSIONS: Positive AFB smear results at the end of completed treatment regimens analyzed in this study have occurred because of unviable bacilli and nontuberculous mycobacteria colonization. The presence of more than one positive smear seems not to increase the probability of treatment failure and is more frequently due to nontuberculous mycobacteria. Results of culture can thus be awaited without the need to prolong or modify antituberculous therapy.

Entities:  

Mesh:

Year:  1996        PMID: 8769512     DOI: 10.1378/chest.109.6.1562

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  13 in total

1.  Application of oxidation-reduction assay for monitoring treatment of patients with pulmonary tuberculosis.

Authors:  Parissa Farnia; Foroazan Mohammadi; Mehdi Mirsaedi; Abolhasan Zia Zarife; Javad Tabatabee; Katayoon Bahadori; Muslem Bahadori; Mohammad Reza Masjedi; Ali Akbar Velayati
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

2.  Field evaluation of a simple fluorescence method for detection of viable Mycobacterium tuberculosis in sputum specimens during treatment follow-up.

Authors:  Birgit Schramm; Cathy Hewison; Laurence Bonte; Warren Jones; Olivier Camélique; Ronnatrai Ruangweerayut; Witaya Swaddiwudhipong; Maryline Bonnet
Journal:  J Clin Microbiol       Date:  2012-05-30       Impact factor: 5.948

3.  Number of sputum specimens during treatment follow-up of tuberculosis patients: two or one?

Authors:  R S Kumar; A M V Kumar; M Claassens; V V Banurekha; N S Gomathi; P Venkatesan; S Swaminathan
Journal:  Public Health Action       Date:  2013-12-21

4.  Mycobacterium tuberculosis microbiologic and clinical treatment outcomes in a randomized trial of immediate versus CD4(+)-initiated antiretroviral therapy in HIV-infected adults with a high CD4(+) cell count.

Authors:  Gabriel Chamie; Edwin D Charlebois; Padmini Srikantiah; Maria Walusimbi-Nanteza; Roy D Mugerwa; Harriet Mayanja; Alphonse Okwera; Christopher C Whalen; Diane V Havlir
Journal:  Clin Infect Dis       Date:  2010-08-01       Impact factor: 9.079

5.  Factors influencing sputum smear conversion at one and two months of tuberculosis treatment.

Authors:  Sumant Pajankar; Rajiv Khandekar; Musallam Amer Al Amri; Mohammed Redha Al Lawati
Journal:  Oman Med J       Date:  2008-10

Review 6.  [Diagnostics for pulmonary tuberculosis in adults].

Authors:  G Laifer; S Bassetti
Journal:  Internist (Berl)       Date:  2007-05       Impact factor: 0.743

7.  The incidence and clinical implication of sputum with positive acid-fast bacilli smear but negative in mycobacterial culture in a tertiary referral hospital in South Korea.

Authors:  Jae Seok Lee; Eui-Chong Kim; Sei Ick Joo; Sang-Min Lee; Chul-Gyu Yoo; Young Whan Kim; Sung Koo Han; Young-Soo Shim; Jae-Joon Yim
Journal:  J Korean Med Sci       Date:  2008-10       Impact factor: 2.153

8.  Comparison of the efficacies of loop-mediated isothermal amplification, fluorescence smear microscopy and culture for the diagnosis of tuberculosis.

Authors:  Geojith George; Prem Mony; John Kenneth
Journal:  PLoS One       Date:  2011-06-17       Impact factor: 3.240

9.  Editorial commentary: dead or alive: can viability staining predict response to tuberculosis treatment?

Authors:  Stephen D Lawn; Mark P Nicol
Journal:  Clin Infect Dis       Date:  2014-12-23       Impact factor: 9.079

10.  Time to culture positivity and sputum smear microscopy during tuberculosis therapy.

Authors:  Ioana D Olaru; Jan Heyckendorf; Susanne Grossmann; Christoph Lange
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.